Laboratory Evaluation for Suspected Hypoparathyroidism
To diagnose hypoparathyroidism and differentiate it from secondary causes of hypocalcemia, order albumin-corrected or ionized calcium with concurrent PTH (2nd or 3rd generation assay), serum phosphate, and serum magnesium—these four tests establish the diagnosis by demonstrating hypocalcemia with inappropriately low or normal PTH, distinguishing primary hypoparathyroidism from secondary hyperparathyroidism where PTH would be elevated. 1
Initial Diagnostic Panel
The diagnosis requires confirmation on two separate occasions at least two weeks apart 1:
- Albumin-corrected calcium OR ionized calcium (low)
- PTH level (inappropriately low or normal—this is the key differentiator)
- Serum phosphate (typically elevated)
- Serum magnesium (must check and correct if abnormal, as hypomagnesemia causes functional hypoparathyroidism)
Critical Diagnostic Distinction
The PTH level is what differentiates primary from secondary causes 2:
- Hypoparathyroidism: PTH is low or inappropriately normal despite hypocalcemia
- Secondary causes (vitamin D deficiency, malabsorption, renal disease): PTH is elevated (appropriate secondary hyperparathyroidism)
- Pseudohypoparathyroidism: PTH is elevated (PTH resistance)
Important caveat: Stop biotin supplementation (if >5 mg daily) for at least 3 days before testing, as it interferes with some PTH assays and can falsely lower results 1.
Comprehensive Biochemical Evaluation After Diagnosis
Once hypoparathyroidism is confirmed, order the following to assess etiology and complications 2, 1:
Vitamin D Assessment
- 25-hydroxyvitamin D (assess stores)
- 1,25-dihydroxyvitamin D (typically low-normal in hypoparathyroidism)
Renal Function and Calcium Handling
- BUN/creatinine and eGFR
- 24-hour urine collection for:
- Calcium excretion (fractional excretion increased despite hypocalcemia)
- Creatinine clearance
- Oxalate and citrate (biochemical stone risk profile)
Additional Markers
- Bone turnover markers (typically low-normal) 1
Etiology-Specific Testing
For Postsurgical Cases
- PTH measured 12-24 hours post-thyroidectomy: If PTH >10 pg/mL (>1.05 pmol/L), permanent hypoparathyroidism is unlikely 1
- Chronic postsurgical hypoparathyroidism is confirmed if hypocalcemia persists ≥12 months after surgery 1
For Nonsurgical/Idiopathic Cases
Genetic testing is advised for 1:
- All patients with idiopathic hypoparathyroidism
- Especially those <40 years old
- Family history of hypoparathyroidism
- Multiple endocrine gland failure or autoimmune features
- Syndromic features suggesting genetic disorders
Imaging and Complication Screening
While not "labs," these are essential for complete evaluation 2, 1:
- Renal ultrasound or CT: Assess for nephrocalcinosis/nephrolithiasis
- Skull X-ray or brain CT: Evaluate for basal ganglia calcifications (especially if neuropsychiatric symptoms or disease duration >5 years)
- Dual-energy X-ray absorptiometry (DXA): Bone mineral density assessment
- ECG: Evaluate for prolonged QTc interval
- Ophthalmologic examination: Screen for cataracts
Common Pitfalls to Avoid
Magnesium deficiency masquerading as hypoparathyroidism: Always check and correct magnesium first, as it causes functional hypoparathyroidism through PTH resistance and impaired PTH secretion 1
Biotin interference: High-dose biotin supplements interfere with PTH assays—ensure 3-day washout 1
Single measurement: Confirm diagnosis with repeat testing at least 2 weeks apart to avoid transient causes 1
Ionized vs. total calcium: If using total calcium, always correct for albumin; ionized calcium is more accurate but requires strict anaerobic collection and immediate measurement 2
PTH assay interpretation: Second-generation PTH assays are most widely used and provide excellent discrimination—inappropriately "normal" PTH in the setting of hypocalcemia is diagnostic, not just "low" PTH 2